These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23331120)

  • 21. Estimated Lifetime Economic Burden of Type 1 Diabetes.
    Sussman M; Benner J; Haller MJ; Rewers M; Griffiths R
    Diabetes Technol Ther; 2020 Feb; 22(2):121-130. PubMed ID: 31886730
    [No Abstract]   [Full Text] [Related]  

  • 22. A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands.
    de Groot S; Enters-Weijnen CF; Geelhoed-Duijvestijn PH; Kanters TA
    BMJ Open; 2018 Mar; 8(3):e019864. PubMed ID: 29581204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus.
    Guo JJ; Gibson JT; Gropper DM; Oswald SL; Barker KN
    Am J Manag Care; 1998 Oct; 4(10):1433-46. PubMed ID: 10338736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin therapy in type 2 diabetes. Insured patients would be willing to pay for added benefits].
    MMW Fortschr Med; 2008 Dec; 150(49-50):56-7. PubMed ID: 19133372
    [No Abstract]   [Full Text] [Related]  

  • 25. Societal costs of multiple sclerosis in Ireland.
    Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
    J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The persistent complication of hypoglycemia in diabetics.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E17. PubMed ID: 25617934
    [No Abstract]   [Full Text] [Related]  

  • 27. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A; Spannheimer A; Reitberger U; Görtz A
    Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should future health-care costs be discounted? The case of diabetes in Australia.
    Scuffham PA
    Intern Med J; 2006 Mar; 36(3):148-9. PubMed ID: 16503948
    [No Abstract]   [Full Text] [Related]  

  • 29. Addressing the burden of diabetes.
    Seaquist ER
    JAMA; 2014 Jun; 311(22):2267-8. PubMed ID: 24915253
    [No Abstract]   [Full Text] [Related]  

  • 30. [Economics under scrutiny - experts discuss long acting insulin analogs].
    Pflege Z; 2011 Jan; 64(1):58. PubMed ID: 21305792
    [No Abstract]   [Full Text] [Related]  

  • 31. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Obesity and diabetes mellitus: increasing problems call for increasing efforts].
    Nauck M
    Dtsch Med Wochenschr; 2010 May; 135(18):901. PubMed ID: 20425673
    [No Abstract]   [Full Text] [Related]  

  • 34. The economic burden of diabetes in India: a review of the literature.
    Yesudian CA; Grepstad M; Visintin E; Ferrario A
    Global Health; 2014 Dec; 10():80. PubMed ID: 25443136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare costs of Type 2 diabetes in Germany.
    Jacobs E; Hoyer A; Brinks R; Icks A; Kuß O; Rathmann W
    Diabet Med; 2017 Jun; 34(6):855-861. PubMed ID: 28199029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Data nail down the astounding cost of diabetes-related care.
    Capitation Rates Data; 2001 Apr; 6(4):42-5. PubMed ID: 11330006
    [No Abstract]   [Full Text] [Related]  

  • 38. Health care use of individuals with diabetes in an employer-based insurance population.
    Laditka SB; Mastanduno MP; Laditka JN
    Arch Intern Med; 2001 May; 161(10):1301-8. PubMed ID: 11371258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of myopic patients with and without myopic choroidal neovascularisation.
    Ruiz-Moreno JM; Roura M;
    Arch Soc Esp Oftalmol; 2016 Jun; 91(6):265-72. PubMed ID: 26900043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial costs for families of children with Type 1 diabetes in lower-income countries.
    Ogle GD; Kim H; Middlehurst AC; Silink M; Jenkins AJ
    Diabet Med; 2016 Jun; 33(6):820-6. PubMed ID: 26482333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.